EVOK Shares Outstanding History



Below is a table of the EVOK shares outstanding history going back to 9/25/2013:

Date EVOK Shares Outstanding
9/25/2013481813
10/31/2013508063
3/20/2014508296
5/2/2014508296
8/1/2014508296
10/31/2014509341
2/23/2015511424
4/30/2015522401
7/31/2015528234
10/31/2015595654
2/29/2016600148
4/30/2016603410
8/9/20161.03M
11/4/20161.03M
3/10/20171.28M
5/5/20171.28M
8/4/20171.28M
11/3/20171.28M
2/28/20181.29M
5/8/20181.40M
8/3/20181.41M
10/31/20181.45M
2/28/20191.45M
4/30/20191.94M
7/31/20192.01M
10/31/20192.02M
2/29/20202.04M
5/7/20202.06M
7/31/20202.17M
11/2/20202.20M
2/28/20212.70M
4/30/20212.70M
7/31/20212.70M
11/1/20212.72M
2/28/20222.74M
5/6/20223.34M
8/5/20223.34M
11/4/20223.34M
2/28/20233.34M
5/10/20233.34M
8/4/20233.34M
11/3/20233.34M
3/1/20248.48M

Also see: EVOK Market Cap History
EVOK YTD Return
EVOK Historical Shares Outstanding:
+31.62% CAGR
EVOK Historical Shares Outstanding: +31.62% CAGR

Mouse over chart for data details
9/25/2013 ...3/1/2024
Evoke Pharma is a pharmaceutical company focused primarily on the development and commercialization of drugs to treat gastrointestinal disorders and diseases. Co. is focused on developing its primary product, Gimoti (metoclopramide) nasal spray. Gimoti is a dopamine antagonist / mixed 5-HT3 antagonist / 5-HT4 agonist for the relief of symptoms associated with acute and recurrent diabetic gastroparesis. Gimoti is a formulation of metoclopramide providing delivery by nasal spray administration. Co. is party to a commercial services agreement with Eversana Life Science Services, LLC, or Eversana, pursuant to which Eversana commercializes and distributes Gimoti in the U.S. We show 43 historical shares outstanding datapoints in our coverage of EVOK's shares outstanding history.

Understanding the changing numbers of EVOK shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like EVOK versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching EVOK by allowing them to research EVOK shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree EVOK Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Evoke Pharma (EVOK) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

EW Shares Outstanding History
EWTX Shares Outstanding History
EXAS Shares Outstanding History
EXEL Shares Outstanding History
EYE Shares Outstanding History
EYEG Shares Outstanding History
EYEN Shares Outstanding History
EYES Shares Outstanding History
EYPT Shares Outstanding History
FATE Shares Outstanding History
More Healthcare companies »

 

EVOK Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.